Nuclear Medicine

Karuna Luthra

Dr. Karuna Luthra

Director
Department
Nuclear Medicine
Qualification

M.B.B.S., D.N.B.

Experience

22 years of experience in Nuclear Medicine

About Us:

Dr. Karuna Luthra is the Director of the Nuclear Medicine Department at Sir H.N. Reliance Foundation Hospital.  

Dr. Luthra is dedicated to driving high-quality diagnostic nuclear medicine services at our hospital via PET-CT and Gamma camera (SPECT-CT) imaging.  She also leads the Theranostic programme where nuclear medicine treatments are now available for treatment of certain cancers.  

Dr. Luthra oversees molecular Targeted Radionuclide Therapy, which is now offered as part of the oncology services at Sir H.N. Reliance Foundation Hospital. She has professionally administered more than 1,000 targeted therapies, including high-dose radioiodine therapy (Thyroid cancer), PRRT (Neuroendocrine tumours), PSMA therapy for advanced Prostate cancer with with Beta (Lu177) and targeted Alpha therapy, TARE for liver tumors, and more.

Her previous professional associations have been as Additional Director of the Nuclear Medicine Department at Jaslok Hospital & Research Centre (Mumbai), Consultant at Lilavati Hospital & Research Centre (Mumbai), being a member of the Tata Memorial Hospital team that performed the first PET-CT in India in 2004, and serving as a lecturer at K.E.M. Hospital (Mumbai).

Dr. Luthra is currently General Secretary of Association of Nuclear Medicine Physicians of India (ANMPI), leading its academic and professional activities. She is also President of the Western Chapter of the Society of Nuclear Medicine, India.  

She is a D.N.B. teacher and examiner for Nuclear Medicine, and has published articles in several national and international journals; she has also authored a book chapter on Nuclear Cardiology.

Dr Karuna believes in our hospital’s principles of ‘excellence in medical services with compassion and care’

Areas of Expertise & Special Interest:

  • PET-CT  - for oncological, Neurological and other non-oncological indications  
  • Expertise with Novel PET-CT imaging - Ga68-DOTATATE, PSMA PET, F-DOPA brain PET for Parkinsons, FAPI PET, Exendin PET, Pentixafor PET, etc
  • Gamma camera and SPECT-CT scans for Cardiology, Endocrinology, Nephro-urology, GI, and other niche indications
  • Targeted Radionuclide Therapy
Bottom to top